This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/519803-china-covid-vaccine-cansinobio/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| China’s CanSinoBIO says its vaccine may be less effective over time, but ‘booster shot’ improves its efficacy to over 90% | China’s CanSinoBIO says its vaccine may be less effective over time, but ‘booster shot’ improves its efficacy to over 90% |
| (5 months later) | |
| A single-shot Covid-19 vaccine by CanSino Biologics has shown a decrease in efficacy over time, the manufacturer has said. Getting a “booster shot” six months after the first jab, however, propels its efficacy to over 90%. | A single-shot Covid-19 vaccine by CanSino Biologics has shown a decrease in efficacy over time, the manufacturer has said. Getting a “booster shot” six months after the first jab, however, propels its efficacy to over 90%. |
| The Chinese vaccine manufacturer CanSinoBIO provided an update on its vaccine during an online presentation late on Wednesday. Its chief scientific officer, Zhu Tao, said receiving a second jab of the vaccine six months after being inoculated with the single-shot solution had shown promising results during tests. | The Chinese vaccine manufacturer CanSinoBIO provided an update on its vaccine during an online presentation late on Wednesday. Its chief scientific officer, Zhu Tao, said receiving a second jab of the vaccine six months after being inoculated with the single-shot solution had shown promising results during tests. |
| “A booster shot six months later led to a seven-times to 10-times increase in neutralizing antibody levels, so we expect in this case efficacy could reach over 90%,” Zhu stated. | “A booster shot six months later led to a seven-times to 10-times increase in neutralizing antibody levels, so we expect in this case efficacy could reach over 90%,” Zhu stated. |
| While the first shot’s efficacy may fall over time, it is still believed to be some 50% effective or more five to six months after inoculation. Nonetheless, more clinical trials data is needed in order to provide more precise estimates, Zhu warned. | While the first shot’s efficacy may fall over time, it is still believed to be some 50% effective or more five to six months after inoculation. Nonetheless, more clinical trials data is needed in order to provide more precise estimates, Zhu warned. |
| The company published first interim trials data back in February, with the vaccine showing a rather modest efficacy of nearly 69% in preventing asymptomatic Covid-19. Its efficacy then steadily dropped over time, measuring some 65% four weeks after the inoculation. | The company published first interim trials data back in February, with the vaccine showing a rather modest efficacy of nearly 69% in preventing asymptomatic Covid-19. Its efficacy then steadily dropped over time, measuring some 65% four weeks after the inoculation. |
| So far, CanSinoBIO’s vaccine has been approved only by a handful of countries, including China, Pakistan, and Mexico. Last week, it also received emergency use approval in Hungary, becoming the second Chinese-made vaccine to be greenlit by the European country. | So far, CanSinoBIO’s vaccine has been approved only by a handful of countries, including China, Pakistan, and Mexico. Last week, it also received emergency use approval in Hungary, becoming the second Chinese-made vaccine to be greenlit by the European country. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |